SCM
DXCM icon

Silvant Capital Management’s DexCom DXCM Stock Holding History

Silvant Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.4M Buy
54,175
+874
+2% +$60.9K 0.12% 102
2025
Q4 		$3.54M Buy
53,301
+856
+2% +$55.3K 0.12% 101
2025
Q3 		$3.53M Sell
52,445
-4,961
-9% -$393K 0.12% 97
2025
Q2 		$5.01M Buy
57,406
+23,978
+72% +$1.88M 0.19% 74
2025
Q1 		$2.28M Hold
33,428
– – 0.11% 116
2024
Q4 		$2.6M Sell
33,428
-210,159
-86% -$15.6M 0.11% 112
2024
Q3 		$16.3M Sell
243,587
-36,702
-13% -$3.01M 0.72% 24
2024
Q2 		$31.8M Buy
280,289
+18,189
+7% +$2.3M 1.41% 16
2024
Q1 		$36.4M Buy
262,100
+1,082
+0.4% +$136K 1.74% 13
2023
Q4 		$32.4M Buy
261,018
+4,397
+2% +$449K 1.74% 13
2023
Q3 		$23.9M Sell
256,621
-1,243
-0.5% -$140K 1.45% 14
2023
Q2 		$33.1M Buy
257,864
+4,864
+2% +$588K 1.86% 11
2023
Q1 		$29.4M Sell
253,000
-3,082
-1% -$345K 1.91% 11
2022
Q4 		$29M Sell
256,082
-27,954
-10% -$3.07M 2.05% 11
2022
Q3 		$22.9M Buy
284,036
+244,240
+614% +$20.7M 1.56% 13
2022
Q2 		$2.97M Sell
39,796
-128
-0.3% -$11.7K 0.72% 31
2022
Q1 		$5.11M Sell
39,924
-836
-2% -$91.4K 0.97% 19
2021
Q4 		$5.47M Sell
40,760
-6,064
-13% -$871K 0.94% 20
2021
Q3 		$6.4M Sell
46,824
-6,204
-12% -$782K 1.14% 16
2021
Q2 		$5.66M Sell
53,028
-532
-1% -$51.1K 0.89% 24
2021
Q1 		$4.81M Sell
53,560
-928
-2% -$87.1K 0.82% 28
2020
Q4 		$5.04M Sell
54,488
-600
-1% -$53.6K 0.86% 22
2020
Q3 		$5.68M Sell
55,088
-9,440
-15% -$986K 1.06% 19
2020
Q2 		$6.54M Buy
64,528
+5,936
+10% +$531K 1.18% 17
2020
Q1 		$3.94M Sell
58,592
-684
-1% -$42.6K 0.86% 24
2019
Q4 		$3.24M Buy
59,276
+37,740
+175% +$1.79M 0.59% 50
2019
Q3 		$804K Hold
21,536
– – 0.16% 98
2019
Q2 		$807K Hold
21,536
– – 0.14% 99
2019
Q1 		$641K Buy
+21,536
New +$757K 0.12% 102

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Silvant Capital Management's DXCM Position: Q1 2026 in Review

Silvant Capital Management increased its DexCom (DXCM) stake by 1.6% in Q1 2026, buying an estimated $60.9K and bringing the position to 54,175 shares worth $3.4M. The position accounts for 0.12% of the portfolio, ranked #102.

Silvant Capital Management first reported a position in DXCM in Q1 2019 and has held it in 29 quarters since. The position peaked at $36.4M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Silvant Capital Management held 54,175 shares of DexCom worth $3.4M as of Q1 2026.
  • Silvant Capital Management bought 874 DexCom shares in Q1 2026, an estimated $60.9K.
  • DexCom made up 0.12% of Silvant Capital Management's portfolio in Q1 2026, its #102 holding.
  • Silvant Capital Management first reported a position in DexCom in Q1 2019 and has held it in 29 quarters since.
  • Silvant Capital Management's DexCom position peaked at $36.4M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.